PI
Pila Pharma AB (publ)
PILA.ST · STO
2.00 kr -10.94% (-0.25 kr)
1M +67.16%
Market Cap 102.3M kr
P/E Ratio -
Div. Yield -
ROE 214.22%
Piotroski F-Score Weak
3/9Valuation
7 /100
Expensive P/B 6.92x
P/S 90.82x
P/FFO N/A
Growth
22 /100
Declining Book val. growth 15.76%
Rev. growth 15.69%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 713.00%
Gross margin 528.70%
FCF margin 588.55%
Quality
1 /100
Poor ROA 104.84%
ROIC 54.34%
Asset turnover 0.07x
Debt
69 /100
Low Int. coverage -803.37x
Debt/Equity 0.00x
Current ratio 11.26x
Stability
27 /100
Unstable EPS volatility 42.60%
Beta -0.30x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PILA.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gustav Hanghoj Gram
Employees
1
Headquarters
Malmö
Prihajajoči dogodki
25 FEB.
Earnings
Upcoming earnings report